AVITA Medical's CEO, Jim Corbett, is satisfied with the comp...
AVITA Medical's CEO, Jim Corbett, is satisfied with the company's growth and is committed to sustaining it in 2024. The ongoing TONE study could influence future business strategies by providing insights into vitiligo's impact on patients' mental health and healthcare costs.
Press Release: AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment